EIF4E and esophageal squamous cell carcinoma: These data indicate that eIF4E promotes PI3K/AKT signaling pathway and Bcl-2/Bax ratio in EC9706, which may imply the possible mechanism of eIF4E induced cisplatin resistance in ESCC.